Archives
- 2018-07
- 2019-06
- 2019-07
- 2019-08
- 2019-09
- 2019-10
- 2019-11
- 2019-12
- 2020-01
- 2020-02
- 2020-03
- 2020-04
- 2020-05
- 2020-06
- 2020-07
- 2020-08
- 2020-09
- 2020-10
- 2020-11
- 2020-12
- 2021-01
- 2021-02
- 2021-03
- 2021-04
- 2021-05
- 2021-06
- 2021-07
- 2021-08
- 2021-09
- 2021-10
- 2021-11
- 2021-12
- 2022-01
- 2022-02
- 2022-03
- 2022-04
- 2022-05
- 2022-06
- 2022-07
- 2022-08
- 2022-09
- 2022-10
- 2022-11
- 2022-12
- 2023-01
- 2023-02
- 2023-03
- 2023-04
- 2023-05
- 2023-06
- 2023-07
- 2023-08
- 2023-09
- 2023-10
- 2023-11
- 2023-12
- 2024-01
- 2024-02
- 2024-03
- 2024-04
- 2024-05
- 2024-06
- 2024-07
- 2024-08
- 2024-09
- 2024-10
- 2024-11
- 2024-12
- 2025-01
- 2025-02
- 2025-03
- 2025-09
- 2025-10
-
Crizotinib Hydrochloride: Illuminating Tumor-Stroma Cross...
2025-10-02
Uncover how Crizotinib hydrochloride, a leading ALK kinase inhibitor, is transforming cancer biology research by dissecting tumor-stroma interactions and resistance mechanisms. Explore its mechanistic depth and advanced applications in assembloid models for unparalleled insight into cancer therapeutics.
-
Imatinib (STI571): Next-Generation Precision for Tyrosine...
2025-10-01
Unlock the scientific potential of Imatinib (STI571), a selective protein-tyrosine kinase inhibitor, in advanced signal transduction and cancer biology research. Discover how its unique selectivity and application in assembloid models advance our understanding of tumor heterogeneity and drug resistance.
-
DMXAA (Vadimezan): Advanced Insights into Tumor Vasculatu...
2025-09-30
Explore how DMXAA (Vadimezan, AS-1404) pioneers a dual paradigm as a vascular disrupting agent and immunomodulator for cancer research. Uncover advanced mechanisms, translational opportunities, and its unique value beyond current literature.
-
Imatinib (STI571): Precision Targeting of Tumor–Stroma In...
2025-09-29
Explore how Imatinib (STI571), a selective protein-tyrosine kinase inhibitor, enables next-generation signal transduction and cancer biology research by dissecting tumor–stroma interactions in complex assembloid models. Discover unique insights into kinase specificity, tumor microenvironment modulation, and personalized drug response.
-
DMXAA (Vadimezan): Next-Generation Tumor Vasculature Disr...
2025-09-28
Discover how DMXAA (Vadimezan, AS-1404) revolutionizes cancer biology research as a vascular disrupting agent and DT-diaphorase inhibitor. This article uniquely explores its integration with endothelial immune signaling and advanced anti-angiogenic strategies.
-
DMXAA (Vadimezan, AS-1404): Next-Generation Vascular Disr...
2025-09-27
Explore the multifaceted role of DMXAA (Vadimezan, AS-1404) as a vascular disrupting agent for cancer research, highlighting its unique mechanisms in tumor vasculature disruption, apoptosis induction, and anti-angiogenic activity. This article provides new insights into DMXAA's integration with endothelial immune signaling and advanced applications in cancer biology.
-
BGJ398 (NVP-BGJ398): Unveiling FGFR Inhibitor Precision i...
2025-09-26
Explore the advanced scientific applications of BGJ398 (NVP-BGJ398), a selective FGFR1/2/3 inhibitor, in both oncology research and developmental biology. This article uniquely bridges mechanistic cancer studies and emerging insights from comparative developmental models, offering a fresh perspective on FGFR-driven malignancies research.
-
Torin2 and Apoptotic Signaling: Decoding mTOR Inhibition ...
2025-09-25
Explore how Torin2, a potent selective mTOR inhibitor, enables advanced cancer research by dissecting apoptosis beyond transcriptional loss. This article uniquely connects Torin2's molecular pharmacology to novel insights in regulated cell death, offering a deeper scientific perspective.
-
BGJ398 (NVP-BGJ398): Unveiling FGFR2-Driven Cancer Biolog...
2025-09-24
Explore the advanced role of BGJ398, a potent FGFR inhibitor, in dissecting FGFR2-driven cancer mechanisms and developmental biology. This article uniquely bridges oncology research with emerging insights from comparative developmental models.
-
BGJ398 (NVP-BGJ398): Dissecting FGFR Signaling and Cell F...
2025-09-23
Explore the mechanistic application of BGJ398 (NVP-BGJ398), a selective FGFR inhibitor, in elucidating FGFR-driven signaling pathways and apoptosis induction in cancer cells. This article highlights emerging research opportunities in developmental biology and oncology.
-
L1023 Anti-Cancer Compound Library: Enabling Targeted Inh...
2025-09-22
The L1023 Anti-Cancer Compound Library provides a robust platform for high-throughput screening of cell-permeable anti-cancer compounds, accelerating the discovery of targeted inhibitors for oncogenic pathways. This article explores its application in the identification of molecular targets and the advancement of precision cancer therapeutics.
-
L1023 Anti-Cancer Compound Library: Advancing High-Throug...
2025-09-19
Explore how the L1023 Anti-Cancer Compound Library empowers high-throughput screening of anti-cancer agents by offering a chemically diverse, cell-permeable collection targeting critical oncogenic pathways. This article discusses its unique value in uncovering molecular targets and accelerating translational cancer research.
-
L1023 Anti-Cancer Compound Library: Accelerating Targeted...
2025-09-18
Explore how the L1023 Anti-Cancer Compound Library enables high-throughput screening of anti-cancer agents and advances targeted drug discovery. This article details its scientific utility for cancer research and highlights its unique value for identifying novel inhibitors.
-
The hypothalamic pituitary adrenal HPA axis is a
2025-03-03
The hypothalamic-pituitary-adrenal (HPA) axis is a neuroendocrine system that is central to regulating responses to stress (Palazidou, 2012). In older persons, a high dysfunction of the HPA axis is observed (Otte et al., 2005) which may be enhanced by stimulatory effects of genes involved in the axi
-
Composite soil samples were transported to
2025-03-03
Composite soil samples were transported to the laboratory and then dried, crushed and passed through a 2mm sieve was. Sample digestion and release of elements method Sposito was performed [15]. Accordingly, taking into account soil moisture to 2g soil samples 12.5ml of nitric acid was added 4M. Samp